Filter
2186
Filtered Results: 2186
Text search:
hepatitis
treatment
Featured
Recommendations
250
New Publications
623
Language
Document type
No document type
1385
Guidelines
326
Studies & Reports
239
Manuals
94
Strategic & Response Plan
60
Training Material
26
Fact sheets
25
Situation Updates
17
Infographics
7
Brochures
3
Resource Platforms
2
App
1
Online Courses
1
Countries / Regions
India
149
Western and Central Europe
56
Global
53
Kenya
51
Nepal
46
South Africa
46
Nigeria
37
Bangladesh
34
Tanzania
33
Liberia
33
Sierra Leone
32
Zambia
31
Myanmar / Burma
30
Uganda
28
Ethiopia
28
Ukraine
26
Latin America and the Carribbean
25
Ghana
24
Rwanda
24
Eastern Europe
24
Philippines
22
Malawi
21
Indonesia
20
Germany
18
Namibia
18
Africa
17
South–East Asia Region
16
Russia
16
Lesotho
15
Asia
15
Argentina
14
Syria
13
Paraguay
13
Colombia
11
Venezuela
10
Albania
9
Zimbabwe
9
Mozambique
9
Brazil
9
Botswana
9
Eswatini/ Swaziland
9
Georgia
8
Congo, Democratic Republic of
7
South Sudan
7
Pakistan
7
Senegal
6
Guinea
6
Cambodia
6
Western Pacific Region
6
Burkina Faso
5
East and Southern Africa
5
Bolivia
5
North Macedonia
4
Tajikistan
4
Cameroon
4
Armenia
4
Eastern Europe and Central Asia
4
Lebanon
4
Papua New Guinea
4
Moldova
4
Timor Leste/ East Timor
3
Chile
3
Afghanistan
3
Peru
3
Sudan
3
Switzerland
2
Thailand
2
Mexico
2
Togo
2
Iran
2
Laos
2
Estonia
2
Hungary
2
Saudi Arabia
2
Middle East and North Africa
2
Vietnam
2
Egypt
2
Central African Republic
2
Poland
2
Libya
2
Bhutan
2
Iraq
2
Somalia
2
Ecuador
2
Serbia
1
Turkey
1
Gambia
1
China
1
Kyrgyzstan
1
Uzbekistan
1
Morocco
1
Qatar
1
USA
1
Haiti
1
Jordan
1
Jamaica
1
Mauritius
1
United Kingdom
1
Norway
1
Portugal
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Sri Lanka
1
Djibouti
1
Yemen
1
Romania
1
Palestine
1
Mali
1
Angola
1
Chad
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
795
Clinical Guidelines
261
Women & Child Health
97
Key Resources
86
Public Health
85
Capacity Building
31
Pharmacy & Technologies
30
Annual Report MEDBOX
1
Toolboxes
HIV
452
TB
203
Mental Health
101
COVID-19
76
Pharmacy
68
Refugee
58
Rapid Response
56
Ebola
51
Caregiver
50
Conflict
39
NTDs
38
AMR
36
Global Health Education
27
Planetary Health
22
NCDs
22
Natural Hazards
20
Zika
8
Polio
7
Cholera
6
Disability
5
Health Financing Toolbox
5
Specific Hazards
2
South Sudan
1
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and...
WPSAR Vol 8, No 4, 2017 | doi: 10.5365/wpsar.2017.8.3.005
DOI: http://dx.doi.org/10.5365/wpsar.v8i4.564
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
